Literature DB >> 3704251

[Status epilepticus in the Lennox-Gastaut syndrome].

C Dravet, O Natale, A Magaudda, J L Larrieu, M Bureau, J Roger, C A Tassinari.   

Abstract

Thirty patients with the Lennox-Gastaut syndrome presenting one or more status epilepticus (the first before age 15) were studied. Triggering factors, semiology, duration, severity and EEG features were considered. A comparison was made between this group of patients and another group having the Lennox-Gastaut syndrome but without status. No significant difference appears in the long-term prognosis, even when status were prolonged. Only three patients died during a status. For this reason the authors recommend prudence and avoidance of very strong treatment. In their experience, intravenous diazepines, intravenous phenytoin and intramuscular ACTH were the most effective drugs.

Entities:  

Mesh:

Year:  1986        PMID: 3704251     DOI: 10.1016/s0370-4475(86)80043-0

Source DB:  PubMed          Journal:  Rev Electroencephalogr Neurophysiol Clin        ISSN: 0370-4475


  4 in total

Review 1.  Medical management of Lennox-Gastaut syndrome.

Authors:  Aspasia Michoulas; Kevin Farrell
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

2.  Surgically amenable epilepsies in children and adolescents: clinical, imaging, electrophysiological, and post-surgical outcome data.

Authors:  Vera C Terra-Bustamante; Regina M F Fernandes; Luciana M Inuzuka; Tonicarlo R Velasco; Veriano Alexandre; Lauro Wichert-Ana; Sandra Funayama; Eliana Garzon; Antonio C Santos; David Araujo; Roger Walz; João A Assirati; Helio R Machado; Américo C Sakamoto
Journal:  Childs Nerv Syst       Date:  2005-05-19       Impact factor: 1.475

3.  Pediatric epilepsy surgery and sudden unexpected death epilepsy: the contribution of a Brazilian epilepsy surgery program.

Authors:  Vera C Terra; Fulvio A Scorza; Esper A Cavalheiro; Lauro Wichert-Ana; Kylvia G F D Pinto; Helio R Machado; Américo C Sakamoto
Journal:  Childs Nerv Syst       Date:  2010-03-02       Impact factor: 1.475

Review 4.  Causes of CNS inflammation and potential targets for anticonvulsants.

Authors:  Mercé Falip; Xavier Salas-Puig; Carlos Cara
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.